The New York Times' Steve Lohr reports at the Bits blog that IBM is using Watson-style software as part of it's "Strategic Intellectual Property Insight Platform," a cloud-based service resulting from "several years of joint development between IBMResearch and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont, and Pfizer." Lohr says the platform "uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical jo

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.